GeoVax Raises $3.6M via Warrant Inducement, Issues 11.4M New Warrants
GOVX is trading near its 52-week low of $0.59 (1.7% above the low).
Summary
GeoVax Labs raised $3.65 million by inducing an existing investor to exercise warrants, issuing 11.4 million new warrants at $0.64 per share in return. The cash extends the company's runway, but the new warrants create substantial potential dilution pending stockholder approval.
Key Events · Financing and Capital Events · GOVX
-
Warrant Inducement Raises $3.65M
Armistice Capital Master Fund Ltd. exercised 5,697,628 existing warrants for approximately $3,646,482 in gross proceeds, before fees.
-
11.4M New Warrants Issued
GeoVax issued 11,395,256 new warrants at $0.64 per share, exercisable only after stockholder approval, expiring five years from approval date.
-
Stockholder Approval Required by Oct 29
Company must hold a stockholder meeting by October 29, 2026 to approve the new warrant exercise; if not obtained, meetings repeat every 90 days.
-
Financial Advisor Fees
A.G.P./Alliance Global Partners receives 7.0% of gross proceeds plus up to $40,000 in legal expense reimbursement.
Analysis · GOVX · Life Sciences
GeoVax Labs entered into a warrant inducement agreement with Armistice Capital Master Fund Ltd. to exercise 5,697,628 existing warrants for approximately $3.65 million in gross proceeds. In exchange, the company issued 11,395,256 new warrants at an exercise price of $0.64 per share, exercisable only after stockholder approval. The transaction provides critical near-term cash for a company that reported only $3.1 million in cash as of July 27, 2026, funding operations only into September 2026. However, the new warrants represent significant potential future dilution, and the company must obtain stockholder approval by October 29, 2026, adding execution risk. The deal also includes a 7.0% financial advisor fee and a $40,000 expense reimbursement to A.G.P./Alliance Global Partners.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1758 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.05%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GOVX was trading at $0.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.59 to $19.21. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.